Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
01.04. | Earnings call: Rubicon Organics reports growth amid industry challenges | 9 | Investing.com | ||
28.03. | Cannabis Producer, Rubicon Organics, Reports Seventh Consecutive Quarter Of Positive Cash Flow & EBITDA | 2 | Benzinga.com | ||
28.03. | Rubicon Organics reports Q4 results | 3 | Seeking Alpha | ||
28.03. | Rubicon Organics Inc: Rubicon loses $1.08-million from operations in 2023 | 2 | Stockwatch | ||
28.03. | Rubicon Organics Reports 2023 Financial Results | 30 | GlobeNewswire (Europe) | Net revenue of $40.1 million for the twelve months ended December 31, 2023Adjusted EBITDA1 of $4.4 million for the twelve months ended December 31, 2023Achieved operating cash flow of $5.0 million... ► Artikel lesen | |
14.03. | Rubicon Organics Inc: Rubicon Organics to release 2023 results March 27 | 3 | Stockwatch | ||
14.03. | Rubicon Organics to Report Q4 2023 Results | 2 | GlobeNewswire (USA) | ||
29.02. | Rubicon Organics Brings 1964 Supply Co. Cannabis-Infused Poutine Sauce to Quebec | 1 | GlobeNewswire (USA) | ||
17.02. | Rubicon Organics Inc: Rubicon Organics warrants to expire Feb. 26 | 4 | Stockwatch | ||
16.02. | Rubicon Organics gets new executive and finance head | 1 | Seeking Alpha | ||
16.02. | Rubicon Organics Inc: Rubicon Organics appoints Brodie as CEO, Risbin as CFO | 1 | Stockwatch | ||
16.02. | Rubicon Organics Announces the Appointment of Chief Executive Officer and Chief Financial Officer, and Grants RSUs | 229 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Feb. 15, 2024 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and... ► Artikel lesen | |
18.01. | Rubicon Organics Grants DSUs and Options | 2 | GlobeNewswire (USA) | ||
13.12.23 | Rubicon Organics Celebrates Double Triumph at 2023 KIND Magazine's Awards | 2 | GlobeNewswire (USA) | ||
15.11.23 | Rubicon Organics Inc: Rubicon loses $1.5-million from operations in Q3 | 2 | Stockwatch | ||
15.11.23 | Rubicon Organics Reports Third Quarter 2023 Financial Results | 251 | GlobeNewswire (Europe) | Net revenue of $10.0 million and $30.1 million for the three and nine months ended September 30, 2023Adjusted EBITDA1 of $1.1 million and $3.1 million for the three and nine months ended September... ► Artikel lesen | |
31.10.23 | Rubicon Organics Inc: Rubicon Organics to release Q3 results Nov. 14 | 2 | Stockwatch | ||
31.10.23 | Rubicon Organics to Report Q3 2023 Results | 1 | GlobeNewswire (USA) | ||
16.10.23 | Rubicon Organics Announces Third Annual Environmental, Social, & Governance Report & Board Appointment | 468 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating and... ► Artikel lesen | |
15.09.23 | Rubicon Organics Announces the Results of Annual General Meeting | 433 | GlobeNewswire (Europe) | VANCOUVER, British Columbia, Sept. 14, 2023 (GLOBE NEWSWIRE) -- Rubicon Organics Inc. (TSXV: ROMJ) (OTCQX: ROMJF) ("Rubicon Organics" or the "Company"), a licensed producer focused on cultivating... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
AURORA CANNABIS | 6,475 | +3,43 % | Kursexplosion bei den Cannabis-Aktien Aurora und Canopy Growth: Jetzt kaufen oder liegen lassen? | Am Donnerstag machten die Cannabis-Aktien von Aurora und Canopy Growth aus einem ganz bestimmten zweistellige Kurssprünge. Sind die Papiere für Anleger jetzt eine Überlegung wert? Mehr als 20 Prozent.... ► Artikel lesen | |
CANOPY GROWTH | 8,140 | +0,49 % | Spotlight on Canopy Growth: Analyzing the Surge in Options Activity | ||
TILRAY BRANDS | 1,624 | -0,76 % | Tilray Aktie: Achterbahnfahrt setzt sich fort | Zum Ende einer bewegten Woche notiert die Aktie des Unternehmens Tilray bei 1.62 €, was einer leichten Veränderung von -0.09% im Vergleich zur Vorwoche entspricht. Die Hoffnungen auf Lockerungen der... ► Artikel lesen | |
INNOCAN PHARMA | 0,191 | +0,79 % | Innocan Pharma leitet FDA-Zulassungsverfahren für Liposomen-Injektionstherapie gegen chronische Schmerzen ein | Mit der Übermittlung eines Antragsschreibens für ein Pre-IND-Meeting leitet Innocan das behördliche Zulassungsverfahren für seine Technologie der verzögerten
CBD-Freisetzung beim Menschen bei... ► Artikel lesen | |
TAAT GLOBAL ALTERNATIVES | 0,161 | -2,13 % | TAAT Global Alternatives Inc.: TAAT Announces Shares for Debt Settlement | ||
CRONOS GROUP | 2,252 | -3,60 % | Cronos Group Inc: Cronos Group to hold Q1 2024 results call May 9 | ||
SYNBIOTIC | 9,540 | +3,02 % | EQS-Adhoc: SynBiotic SE: SynBiotic schließt Einbringungsvertrag über den Erwerb aller Anteile an der Ilesol Pharmaceuticals d.o.o. (Kroatien) | EQS-Ad-hoc: SynBiotic SE / Schlagwort(e): Firmenübernahme/Beteiligung/Unternehmensbeteiligung
SynBiotic SE schließt Einbringungsvertrag über den Erwerb aller Anteile an der Ilesol... ► Artikel lesen | |
TRANSCANNA | 0,017 | -100,00 % | TransCanna Holdings Inc. Announces Closing of Loan Upsize | Vancouver, British Columbia--(Newsfile Corp. - December 22, 2023) - TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") today announces that is has entered into a second... ► Artikel lesen | |
BEVCANNA ENTERPRISES | 1,245 | -3,11 % | Bevcanna Enterprises Inc (3): Bevcanna to issue 169,816 shares for debt | ||
DIGICANN VENTURES | 0,002 | -63,64 % | XFRA NEW INSTRUMENTS AVAILABLE ON XETRA - 26.01.2024 | The following instruments on XETRA do have their first trading 26.01.2024 Die folgenden Instrumente in XETRA haben ihren ersten Handelstag 26.01.2024
Aktien
1 KYG7006A1094 Perfect Corp.
2 JP3501950004... ► Artikel lesen | |
ORGANIGRAM | 1,756 | +1,04 % | ORGANIGRAM HOLDINGS INC. - 6-K, Report of foreign issuer | ||
CRESCO LABS | 1,833 | +0,60 % | Cresco Labs cannabis cultivation employees in Massachusetts ditch union | ||
GREEN THUMB INDUSTRIES | 11,140 | +1,18 % | Green Thumb Industries Inc: Green Thumb to open Rise Dispensary Wesley Chapel | ||
MYDECINE INNOVATIONS GROUP | 0,010 | -4,76 % | Mydecine Innovations Group Inc.: Mydecine Announces Intention to Refile Certain Financial Statements and Applies for Management Cease Trade Order | ||
SNDL | 1,813 | -0,49 % | Peering Into SNDL's Recent Short Interest |